[Efficacy of therapeutic use of ultrasound and sinusoidal modulated currents combed with halotherapy in patient with occupational toxic-dust bronchitis]. / Effektivnost' lechebnogo primeneniia ul'trazvuka i sinusoidal'nykh modulirovannykh tokov v komplekse s galoterapie u bol'nykh professional'nym toksiko-pylevym bronkhitom.

Immunological and cardiorespiratory characteristics were studied in 88 alloy industry workers with occupational toxic-dust bronchitis who received the following therapy: sinusoidal modulated currents (SMC), ultrasound (US) on the chest, halotherapy (HT) (52 patients, group 1); SMC + HT (10 patients, group 2); US + HT (15 patients, group 3); HT (11 patients, group 4). The patients did also therapeutic exercise and were massaged (chest). It was found that device physiotherapy (SMC, US) in combination with HT raise the treatment efficacy to 86.5%. This combined treatment is recommended both for treatment and prevention of obstructive syndrome in toxic-dust bronchitis.

[Heparin electrophoresis by sinusoidal modulated currents in the combined treatment of chronic fetoplacental insufficiency]. / Geparin-élektroforez sinusoidal'nymi modulirovannymi tokami v kompleksnom lechenii khronicheskoi fetoplatsentarnoi nedostatochnosti.

Physicochemical grounds are presented for application of heparin electrophoresis with sinusoidal modulated currents (SMC) for correction of impaired fetouteroplacental circulation and blood rheocoagulation basing on the evidence obtained in 95 gravidae on gestation trimester II. 25% of them were in the group of risk by chronic fetoplacental insufficiency (CFPI), 63% had compensated CFPI and 12% of patients--subcompensated CFPI. 50 patients were treated with drugs SMC heparin electrophoresis, 25 patients received SMC and basic medication, 20 patients were given drugs only. Compared to drugs or SMC treatment only, SMC heparin electrophoresis produced more beneficial effects on hemostasis, barrier placental function, reduced frequency of premature and operative labour.

[A new method for treating rheumatoid arthritis patients by electrophoresis using mefenamic acid]. / Novyi metod lecheniia bol'nykh revmatoidnym artritom élektroforezom s primeneniem mefenamovoi kisloty.

The paper provides clinical and experimental reasoning for application of a new treatment for rheumatoid arthritis (RA) implying electrophoresis of an anti-inflammatory drug mefenamic acid from dimexide solution. Complete and partial responses registered in 125 patients, reached 75%. With the new method it is possible to relieve pain, correct immunity and stop inflammation. The best effect was shown in an inactive disease and in activity phases I and II in adjuvant use of the method.

[Acetylsalicylic acid ultraphonophoresis in the treatment of the pain syndrome in patients with lumbar osteochondrosis]. / Ul'trafonoforez atsetilsalitsilovoi kisloty v lechenii bolevogo sindroma u bol'nykh poiasnichnym osteokhondrozom.

Data are reported of an experimental-clinical substantiation and therapeutic use of acetylsalicylic acid ultraphonophoresis of pain syndromes of radicular and reflex genesis in 144 patients with lumbar osteochondrosis. Improvement was noted in 57.3% in severe pain, 31.2% in moderate pain, and 75% in mild pain. Aspirin ultraphonophoresis was effective in pain syndrome of radicular genesis in 71% of cases and in 60.5% of reflex genesis.

[The use of the electrophoresis of water-insoluble preparations of fencarol and parmidine from dimexide solutions]. / Primenenie élektroforeza vodonerastvorimykh preparatov fenkarola i parmidina iz rastvorov dimeksida.

Hepatic mitochondrial respiration was recorded by polarography in various metabolic states using relevant substrates and inhibitors in rat male experiments in vivo and in vitro. The above measurements were made following electrophoresis of parmidine and phencarol in 50% dimexide solution. Parmidine from dimexide solution proved indifferent to mitochondrial energy apparatus, while phencarol could inhibit NADH-dehydrogenase link of the respiratory chain and arrest dimexide inhibition of succinate oxidase system. The findings provided a basis for therapeutic procedures which were tested in 105 patients. The immediate response of coronary and neurodermatitis patients appeared satisfactory.